Skip to main content
. Author manuscript; available in PMC: 2012 Feb 16.
Published in final edited form as: Cytotherapy. 2010 Sep 27;12(8):1013–1021. doi: 10.3109/14653249.2010.515580

Figure 1.

Figure 1

Treatment schema. IL-2 was administered on day 1 and continued until completion of leukapheresis. GM-CSF and G-CSF were started on day 7 and continued until completion of leukapheresis.